European Organization for Research and

Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000 92(3) 205-216. 

EORTC European Organization for Research and Treatment of Cancer... 

Bartehnk H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997 15 2040-2049. 

Eschwege F, Sancho-Garnier H, Gerard JP, et al. Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx experience of the European Organization for Research and Treatment of Cancer. NCI Monogr 1988 6 275-278. 

Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996 88 890-899. 

Cave H, van der Werff ten Bosch J, Suciu S et al. European Organization for Research and Treatment of Cancer-Childhood Leukemia Cooperative Group. Clinical significance of minimal residual disease in childhood acute lymphoblastie leukemia. N Engl J Med 1998 339 591-598. 

Schroder FH, Whelan P, De Reijke TM, Kurth KH, Pavone-Macaluso M, Mattelaer J, Van Velthoven RF, Debois M, Collette L. Metastatic prostate cancer treated by flutamide versus cyproterone acetate final analysis of the European Organization for Research and Treatment of Cancer (EORTC) protocol 30892. Eur Urol 2004 45 457-64. 

Bernier J, Stratford MRL, Denekamp J, Dennis MF, Bieri S, Hagen F., Kocagoncu O, Bolla M, Rojas A. Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy the experience of the cooperative group of radiotherapy of the European Organization for Research and Treatment of Cancer. Radiother Oncol 1998 48 123-33. 

Bernier J, Denekamp J, Rojas A, Minatel E, Horiot J-C, Hamers H, Antognoni P, Dahl O, Richaud P, Van Glabbeke M, Pierart M. ARCON Accelerated Radiotherapy with Carbogen and Nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer (EORTC). Radiother Oncol 2000 55 111-19. 

Schoffski P, Riggert S, Fumoleau P, et al. Phase 1 trial of intravenous Aviscumine (rViscumin) in patients with solid tumors. A study of the European Organization for Research and Treatment of Cancer (EORTC) New Drug Development Group (NDDG). Ann Oncol 2004 15(12) 1816-1824. 

P2. Paulli, M., Berti, E., Rosso, R., Boveri, E., Kindi, S., Klersy, C., Lazzarino, M., Borroni, G., Menestrina, F., Santucci, M., et al. CD30/Ki-1-positive lymphoproliferative disorders of the skin—Clinicopathologic correlation and statistical analysis of 86 cases A multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. J. Clin. Oncol. 13, 1343-1354 (1995). 

W6. Willemze, R., Kerl, H., Sterry, W., Berti, E., Cerroni, L., Chimenti, S., Diaz-Perez, J. L., Geerts, M. L., Goos, M., Knobler, R., Ralfkiaer, E., Santucci, M., Smith, N., Wechsler, J., van Vloten, W. A., and Meijer, C. J., EORTC classification for primary cutaneous lymphomas A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and... 

Duval, M., Suciu, S., Ferster, A., Rialland, X., Nelken, B., Lutz, P., Benoit, Y., Robert, A., Manel, A. M., Vilmer, E., Otten, J. and Philippe, N. (2002). Comparison of Escherichia coli-asparaginase with Erwin V/-asparaginasc in the treatment of childhood lymphoid malignancies results of a randomized European Organization for Research and Treatment of Cancer-Children s Leukemia Group phase 3 trial. Blood 99, 2734-2739. 

De Wit R, Roberts )T, Wilkinson PM et al. (2001) Equivalence of three or four cycles of bleomycin, etoposide and cisplatin chemotherapy and of a 3- or 5-day schedule in good prognosis germ cell cancer a randomised study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cooperative Group and the Medical Research Council. Journal of Clinical Oncology 19 1629-1640. 

He has served as the director of the Istituto Farmacochimico (March 1995-June 1999) and director of the Dipartimento Farmacochimico Toss. Biol. (July 1999-December 2004 and July 2005-to date). He is responsible for ERASMUS exchanges of the Faculty of Pharmacy of the University of Palermo for the research sector Synthetic Analogues of Natural Structure of Biological Interest of the ICTPN-CNR in a scientific capacity (January 1994—December 1998). He has been Member of the Drug Discovery Committee of the European Organization for Research and Treatment of Cancer, the Societa Chimica Italiana, Member, and the International Society of Heterocyclic Chemistry (which he has also served in the capacity of vice-president for the period 2004—05). He is a scientific editor of the journal ARKIVOC. 

Oosterlinck W, Kurth KH, Schroder F, Bultinck J, Hammond B, Sylvester R. A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical... 

Vegt PD, van der Meijden AP, Sylvester R, Brausi M, Holtl W, de Balincourt C, Andriole GL. Does isoniazid reduce side effects of intravesical Bacillus Calmette-Guerin therapy in superficial bladder cancer Interim results of European Organization for Research and Treatment of Cancer Protocol 30911. J Urol 1997 157(4) 1246-9. 

Shepherd FA, Giaccone G, Seymour L, et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemodierapy in patients widi small-cell lung cancer A trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002 20 4434 439. 

EBVP epirubicin, bleomycin, vinblastine, and prednisone EORTC European Organization for Research and Treatment of Cancer... 

Lowenberg B, Zittoun R, Kerkhofs H, et al. On the value of intensive remission-induction chemotherapy in elderly patients of 65 + years with acute myeloid leukemia a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group. J Clin Oncol 1989 7 1268-1274. 

Parideans R, Biganzoli L, Bruning P, et al. Pa-clitaxel versus doxorubicin as first-line singleagent chemotherapy for metastatic breast cancer a European organization for research and treatment of cancer randomized study with cross-over. J Clin Oncol 2000, 18, 724-733. 

---